Exxon, Shell File Move for Genetic Testing of Plaintiff’s Tissue and Blood



DOCUMENTS
  • Motion


GRETNA, La. –– Defendants Exxon Mobil Corp. and Shell Oil Co. are seeking access to a plaintiff’s tissue and blood, saying that genetic testing will indicate whether the plaintiff has an “inherited propensity or susceptibility” to develop his cancer.

In the Aug. 28 motion filed in Louisiana’s 24th Judicial District Court for Jefferson Parish, Exxon Mobil Corp. and Shell Oil Co. seek testing of the plaintiff’s tissue and blood, specifically from the plaintiff’s kidney, adrenal gland and lymph nodes.

The motion additionally seeks a blood sample from the plaintiffs to be taken at the office of Dr. John …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

April 08, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's Data Breach Litigation Conference

March 26, 2025 - Charlotte, NC
Omni Charlotte Hotel

MORE DETAILS